CBS62logoNEW2013_blue_final_header_White wwj950-sm2011b 971-ticket-35smb 35h_CBSSportsRad_Detroit
LARRY DELISLE BREAKS SILENCE 25 YEARS AFTER DRIVING KIDS INTO DETROIT RIVER - READ MORE

DNA Interference

ProNAi

ProNAi To Present Phase II Clinical Data For New Cancer Drug

ProNAi Therapeutics Inc., a developer of drugs that target cancer by interfering with cancer cells’ DNA, announced that data from its ongoing Phase II clinical study of its drug candidate PNT2258 will be presented at the 55th Annual Meeting of the American Society of Hematology in New Orleans Dec. 7-10.

WWJ Newsradio 950–11/10/2013

ProNAi

ProNAi Presents Cancer Drug Results, Expands Management Team

ProNAi Therapeutics Inc., a cancer drug development company, said last week that it had concluded its initial human clinical trial of PNT2258, a new type of nucleic acid drug.

WWJ Newsradio 950–11/11/2012